Awesome Chemistry Experiments For 111-24-0

After consulting a lot of data, we found that this compound(111-24-0)Quality Control of 1,5-Dibromopentane can be used in many types of reactions. And in most cases, this compound has more advantages.

So far, in addition to halogen atoms, other non-metallic atoms can become part of the aromatic heterocycle, and the target ring system is still aromatic.Zeslawska, Ewa; Kucwaj-Brysz, Katarzyna; Kincses, Annamaria; Spengler, Gabriella; Szymanska, Ewa; Czopek, Anna; Marc, Malgorzata Anna; Kaczor, Aneta; Nitek, Wojciech; Dominguez-Alvarez, Enrique; Latacz, Gniewomir; Kiec-Kononowicz, Katarzyna; Handzlik, Jadwiga researched the compound: 1,5-Dibromopentane( cas:111-24-0 ).Quality Control of 1,5-Dibromopentane.They published the article 《An insight into the structure of 5-spiro aromatic derivatives of imidazolidine-2,4-dione, a new group of very potent inhibitors of tumor multidrug resistance in T-lymphoma cells》 about this compound( cas:111-24-0 ) in Bioorganic Chemistry. Keywords: arylpiperazinyl spiroimidazolidinedione preparation docking antitumor crystal multidrug resistance lymphoma; Crystal structure; Fluorene; Hydantoin; Multidrug resistance; P-glycoprotein (ABCB1); T-lymphoma. We’ll tell you more about this compound (cas:111-24-0).

A series of arylpiperazine derivatives of the 5-spiroimidazolidine-2,4-diones I/I·HCl (n = 3, 4, 5; R = Ph, Bn, 4-nitrophenyl, diphenylmethyl, 3-chlorophenyl), II (m = 1, 2; R1 = H, CF3) and III has been explored, including variations in the number of aromatic rings at position 5 and the length of the linker, as well as the kind and position of the linked arylpiperazine terminal fragment. Synthesis I/I·HCl and X-ray crystallog. studies for representative compounds I (n = 4; R = Bn), I·HCl (n = 3, R = Bn; n = 5, R = Ph) and II (m = 2; R1 = H (III)) have been performed. The ability to inhibit the tumor multidrug resistance (MDR) efflux pump P-glycoprotein (P-gp, ABCB1) overexpressed in mouse T-lymphoma cells was investigated. The cytotoxic and antiproliferative actions of the compounds on both the reference and the ABCB1-overproducing cells were also examined The pharmacophore-based mol. modeling studies have been performed. ADMET properties in vitro of selected most active derivatives I (n = 4; R = 4-nitrophenyl) and I·HCl (n = 3, R = Ph; n = 4, R = diphenylmethyl (IV)) have been determined All compounds, excluding III, inhibited the cancer P-gp efflux pump with higher potency than that of reference verapamil. The spirofluorene derivatives with amine alkyl substituents at position 1, and the Me group at position 3 (I/I·HCl), occurred the most potent P-gp inhibitors in the MDR T-lymphoma cell line. In particular, compounds I·HCl (n = 3; R = 4-nitrophenyl) and IV were 100-fold more potent than verapamil. Crystallog.-supported pharmacophore-based SAR anal. has postulated specific structural properties that could explain this excellent cancer MDR-inhibitory action.

After consulting a lot of data, we found that this compound(111-24-0)Quality Control of 1,5-Dibromopentane can be used in many types of reactions. And in most cases, this compound has more advantages.

Reference:
Chiral nitrogen ligands in late transition metal-catalysed asymmetric synthesis—I. Addressing the problem of ligand lability in rhodium-catalysed hydrosilations,
Nitrogen-Containing Ligands for Asymmetric Homogeneous and Heterogeneous Catalysis